Research map: Real-World Body Composition and Blood Pressure Changes Following Glucagon-Like Peptide 1 Receptor Agonist Initiation: A Causal Inference Study of Connected Device Data

Back to the article

Papers in this map

  1. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes · Steven P. Marso · 2016 · 7637 citations · Cited by this paper
  2. Artificial Intelligence Research as a Continuous Clinical Service · 2025 · Related
  3. Once-Weekly Semaglutide in Adults with Overweight or Obesity · John P.H. Wilding · 2021 · 5054 citations · Cited by this paper
  4. Rethinking Cardiopulmonary Bypass Management in The Digital Health Era · 2026 · Related
  5. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis · Dena Ettehad · 2015 · 3805 citations · Cited by this paper
  6. Reviewers for Mayo Clinic Proceedings: Digital Health (2025) · 2025 · Related
  7. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes · A. Michael Lincoff · 2023 · 3058 citations · Cited by this paper
  8. Diagnostic Accuracy of Clinical Decision Support Systems ORADIII and ORAD DDx to Histopathological Diagnosis of Jaw Lesions · 2025 · Related
  9. Functional Data Analysis for Sparse Longitudinal Data · Fang Yao · 2005 · 1640 citations · Cited by this paper
  10. Accuracy of VO2 max Estimates From Apple Watch Series 10 · 2026 · Related
  11. Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis · Kazem Rahimi · 2021 · 1064 citations · Cited by this paper
  12. Electronic Health Records and Their Role in the Surveillance of Infectious Disease · 2025 · Related
  13. Glucagon-like peptide 1 receptor agonists: cardiovascular benefits and mechanisms of action · John R. Ussher · 2023 · 566 citations · Cited by this paper
  14. Wearable Sleep Measures May Improve Machine Learning Prediction of Home-Based Pulmonary Rehabilitation Engagement Among Patients With Chronic Obstructive Pulmonary Disease: A Proof-of-Concept Study · 2026 · Related
  15. PIONEER 1: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes · Vanita R. Aroda · 2019 · 485 citations · Cited by this paper
  16. Relational Artificial Intelligence as a Developmental Exposure in Adolescence: A Precautionary Perspectives and Controversies Article · 2026 · Related
  17. Changes in lean body mass with glucagon‐like peptide ‐1‐based therapies and mitigation strategies · Ian J. Neeland · 2024 · 382 citations · Cited by this paper
  18. Foundation Models as a New Portable Standard in Local Risk Stratification for Emergency Surgery · 2025 · Related
  19. Weight loss composition is one‐fourth fat‐free mass: a critical review and critique of this widely cited rule · Steven B. Heymsfield · 2014 · 347 citations · Cited by this paper
  20. DD-NeuralNet: Dual-Domain Neural Network for Enhanced Multi-Lead ECG Decision Support · 2025 · Related
  21. Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Glp-1 Receptor Agonists: A Multidisciplinary Expert Consensus · Juan José Gorgojo Martínez · 2022 · 340 citations · Cited by this paper
  22. Effects of Different Dietary Interventions on Blood Pressure · Hawkins C. Gay · 2016 · 230 citations · Cited by this paper
  23. A Review of the Effects of Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors on Lean Body Mass in Humans · Jack Alistair Sargeant · 2019 · 227 citations · Cited by this paper
  24. Oral semaglutide improves body composition and preserves lean mass in patients with type 2 diabetes: a 26-week prospective real-life study · Sara Volpe · 2023 · 72 citations · Cited by this paper
  25. Impact of Semaglutide on fat mass, lean mass and muscle function in patients with obesity: The SEMALEAN study · Mathieu Alissou · 2025 · 58 citations · Cited by this paper
  26. Intent-to-Treat (ITT) vs Completer or Per-Protocol Analysis in Randomized Controlled Trials · Chittaranjan Andrade · 2022 · 51 citations · Cited by this paper
  27. Accuracy of the Withings BPM Connect Device for Self-Blood Pressure Measurements in General Population – Validation According to the Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization Universal Standard · Jirar Topouchian · 2022 · 16 citations · Cited by this paper
  28. Seasonal variation in home blood pressure and its relationship with room temperature in patients with type 2 diabetes · Emi Ushigome · 2019 · 13 citations · Cited by this paper
  29. Validation of the Withings BPM Core Device for Self-Blood Pressure Measurements in General Population According to the Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization Universal Standard · Zoya Hakobyan · 2023 · 6 citations · Cited by this paper
  30. Once-Weekly Semaglutide Improves Body Composition in Spanish Obese Adults with Type 2 Diabetes: A 48-Week Prospective Real-Life Study · Irene Caballero Mateos · 2025 · 5 citations · Cited by this paper
  31. Challenges in Causal Inference from Personal Monitoring Devices · Tomasz Wiktorski · 2018 · 2 citations · Cited by this paper
  32. Causal inference with a functional outcome · Kreske Ecker · 2023 · 2 citations · Cited by this paper

Source: OpenAlex (CC0)